http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107184972-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_805c4456058924190338e401a650d3f0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
filingDate 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8942d09d5077a0ef4d29ddce54ddfbfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2860e04b4b1038c786fd0298d8f72390
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c52c89aa97a0339b8c7ce5d2fb85305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f79aa0302f381b75a50144d65254da11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5768e943e69283e13b72cae52f3813f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e87a762fece6a713eb3193eb0c7b8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c2dbb91f949dde8a93eb16133f5766a
publicationDate 2017-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107184972-A
titleOfInvention A kind of mycobacterium tuberculosis OS-tb oligosaccharide conjugate and its preparation method and application
abstract The present invention provides a Mycobacterium tuberculosis OS-tb oligosaccharide conjugate and its preparation method and application. In said Mycobacterium tuberculosis OS-tb oligosaccharide conjugate, the chemical structure of the oligosaccharide is clear and single, instead of The mixture can be synthesized in large quantities by chemical methods, and the antigen can be prepared by coupling the linker with the carrier, which can solve the problem of low and unstable immune protection of BCG vaccine, and can also produce better immunity for some special groups with low immunity effect, and has wide application value in the preparation of tuberculosis vaccines.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110724189-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110724189-A
priorityDate 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466244625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467137999

Total number of triples: 28.